In this new Law360 article, Akerman Healthcare Partner Jordan Cohen highlighted that upcoming IPOs from digital health companies like Hinge Health and Omada Health are seen as pivotal for the sector’s future. He described these IPOs as “poster child” events that could signal broader trends, generating significant anticipation in the industry. Cohen noted that successful offerings could boost valuations across digital health, benefiting both public and private companies. He emphasized that positive IPO outcomes might improve purchase prices for private equity and strategic buyers, but also acknowledged concerns about market volatility and trade policy uncertainty.

"If the IPOs go well, and they support steeper valuations on the digital health side, that could affect a private equity or a strategic buyer's proposed purchase price," Cohen told the publication. "Everybody is pulling for [Hinge and Omada] to do well, but there is also some concern about the fits and starts of the trade policy leaving a lot to be desired" in terms of certainty in the M&A markets.